Transcranial Magnetic stimulation in Neurodegenerative Diseases: Basics and Clinical Applications
Author:
YULUĞ Burak,ASLAN Ahmet
Publisher
Acta Medica Alanya
Reference10 articles.
1. 1-Eschweiler G.W. (2003) Entwicklung der transkraniellen Magnetstimulation (TMS). In: Eschweiler G.W., Wild B., Bartels M. (eds) Elektromagnetische Therapien in der Psychiatrie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57370-5_16
2. 2- Yulug B. Neuroprotective treatment strategies for poststroke mood disorders: A minireview on atypical neuroleptic drugs and selective serotonin re-uptake inhibitors. Brain Res Bull. 2009 Sep 28;80(3):95-9. doi: 10.1016/j.brainresbull.2009.06.013. Epub 2009 Jul 1. PMID: 19576272.
3. 3- Caglayan B, Kilic E, Dalay A, et al. Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in mice. Mol Biol Rep. 2019;46(1):241-250. doi:10.1007/s11033-018-4465-4
4. 4-Lapchak, Paul A., and John H. Zhang, eds. Neuroprotective therapy for stroke and ischemic disease. Switzerland: Springer International Publishing, 2017. doi:10.1007/978-3-319-45345-3
5. 5- Hanoglu L, Velioglu HA, Hanoglu T, Yulug B. Neuroimaging-Guided Transcranial Magnetic and Direct Current Stimulation in MCI: Toward an Individual, Effective and Disease-Modifying Treatment [published online ahead of print, 2021 Nov 9]. Clin EEG Neurosci. 2021;15500594211052815. doi:10.1177/15500594211052815